General Information of Drug Transporter (DT)
DT ID DTD0501 Transporter Info
Gene Name SLCO3A1
Protein Name Organic anion transporting polypeptide 3A1
Gene ID
28232
UniProt ID
Q9UIG8
Genetic Polymorphisms of DT (GPD)
Genetic Polymorphism rs1517618
Site of GPD chr15:92104415 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP G>A / G>C
Minor Allele Frequency G=0.1010/199 (Global)
 Allele G Click to Show/Hide the Full List of Affected Drugs:           4 Drugs in Total
Efavirenz N.A. Hyponatremia Allele G is not associated with increased resistance to efavirenz, lamivudine, nevirapine and zidovudine in people with HIV Infections as compared to allele C. [ 1]
Lamivudine N.A. Hyponatremia Allele G is not associated with increased resistance to efavirenz, lamivudine, nevirapine and zidovudine in people with HIV Infections as compared to allele C. [ 1]
Nevirapine N.A. Hyponatremia Allele G is not associated with increased resistance to efavirenz, lamivudine, nevirapine and zidovudine in people with HIV Infections as compared to allele C. [ 1]
Zidovudine N.A. Hyponatremia Allele G is not associated with increased resistance to efavirenz, lamivudine, nevirapine and zidovudine in people with HIV Infections as compared to allele C. [ 1]
Genetic Polymorphism rs8027174
Site of GPD chr15:91941607 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP G>T
Minor Allele Frequency G=0.9510/1882 (Global)
 Genotypes GT + TT Click to Show/Hide the Full List of Affected Drugs:           1 Drugs in Total
Darunavir N.A. Hyponatremia Genotypes GT + TT is associated with decreased clearance of darunavir in people with HIV Infections as compared to genotypes GG + TT. [ 2]
Genetic Polymorphism rs4294800
Site of GPD chr15:91917464 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP A>C / A>G / A>T
Minor Allele Frequency A=0.2650/524 (Global)
 Genotype AA Click to Show/Hide the Full List of Affected Drugs:           1 Drugs in Total
Darunavir N.A. Hyponatremia Genotype AA is associated with increased volume of distribution of darunavir in people with HIV Infections as compared to genotypes AG + GG. [ 2]
References
1 ABCB1 and ABCC1 variants associated with virological failure of first-line protease inhibitors antiretroviral regimens in Northeast Brazil patients. J Clin Pharmacol. 2013 Dec;53(12):1286-93.
2 Simultaneous pharmacogenetics-based population pharmacokinetic analysis of darunavir and ritonavir in HIV-infected patients. Clin Pharmacokinet. 2013 Jul;52(7):543-53.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.